The Tie2 antagonist rebastinib reduces ovarian cancer growth in a syngeneic murine model.

Saved in:
Bibliographic Details
Title: The Tie2 antagonist rebastinib reduces ovarian cancer growth in a syngeneic murine model.
Authors: Gupta VG; Department of Obstetrics and Gynecology, Washington University School of Medicine, 660 S. Euclid Avenue, Mailstop 8064-37-1005, Saint Louis, MO, 63110, USA. ggupta@wustl.edu., Roby KF; Department of Cell Biology and Physiology, The University of Kansas Medical Center, Kansas City, KS, USA., Pathak HB; Department of Pathology, The University of Kansas Medical Center, Kansas City, KS, USA., Godwin AK; Department of Pathology, The University of Kansas Medical Center, Kansas City, KS, USA., Gunewardena S; Department of Cell Biology and Physiology, The University of Kansas Medical Center, Kansas City, KS, USA., Khabele D; Department of Obstetrics and Gynecology, Washington University School of Medicine, 660 S. Euclid Avenue, Mailstop 8064-37-1005, Saint Louis, MO, 63110, USA. khabeled@wustl.edu.
Source: BMC cancer [BMC Cancer] 2025 Feb 11; Vol. 25 (1), pp. 233. Date of Electronic Publication: 2025 Feb 11.
Publication Type: Journal Article
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39930466
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The Tie2 antagonist rebastinib reduces ovarian cancer growth in a syngeneic murine model.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Gupta+VG%22">Gupta VG</searchLink>; Department of Obstetrics and Gynecology, Washington University School of Medicine, 660 S. Euclid Avenue, Mailstop 8064-37-1005, Saint Louis, MO, 63110, USA. ggupta@wustl.edu.<br /><searchLink fieldCode="AU" term="%22Roby+KF%22">Roby KF</searchLink>; Department of Cell Biology and Physiology, The University of Kansas Medical Center, Kansas City, KS, USA.<br /><searchLink fieldCode="AU" term="%22Pathak+HB%22">Pathak HB</searchLink>; Department of Pathology, The University of Kansas Medical Center, Kansas City, KS, USA.<br /><searchLink fieldCode="AU" term="%22Godwin+AK%22">Godwin AK</searchLink>; Department of Pathology, The University of Kansas Medical Center, Kansas City, KS, USA.<br /><searchLink fieldCode="AU" term="%22Gunewardena+S%22">Gunewardena S</searchLink>; Department of Cell Biology and Physiology, The University of Kansas Medical Center, Kansas City, KS, USA.<br /><searchLink fieldCode="AU" term="%22Khabele+D%22">Khabele D</searchLink>; Department of Obstetrics and Gynecology, Washington University School of Medicine, 660 S. Euclid Avenue, Mailstop 8064-37-1005, Saint Louis, MO, 63110, USA. khabeled@wustl.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100967800%22">BMC cancer</searchLink> [BMC Cancer] 2025 Feb 11; Vol. 25 (1), pp. 233. <i>Date of Electronic Publication: </i>2025 Feb 11.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100967800 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1471-2407 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214712407%22">14712407 </searchLink><i>NLM ISO Abbreviation: </i>BMC Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39930466
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s12885-025-13640-z
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 233
    Titles:
      – TitleFull: The Tie2 antagonist rebastinib reduces ovarian cancer growth in a syngeneic murine model.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Gupta VG
      – PersonEntity:
          Name:
            NameFull: Roby KF
      – PersonEntity:
          Name:
            NameFull: Pathak HB
      – PersonEntity:
          Name:
            NameFull: Godwin AK
      – PersonEntity:
          Name:
            NameFull: Gunewardena S
      – PersonEntity:
          Name:
            NameFull: Khabele D
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 11
              M: 02
              Text: 2025 Feb 11
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1471-2407
          Numbering:
            – Type: volume
              Value: 25
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: BMC cancer
              Type: main
ResultId 1